Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections

Journal of Clinical Microbiology

Volumn 42, Issue 6, 2004, Pages 2476-2479

  Hermann, Corinna ^a   Gueinzius, Katja ^a   Oehme, Albrecht ^b   Von Aulock, Sonja ^a   Straube, Eberhard ^c   Hartung, Thomas ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; CHILD; CHLAMYDOPHILA PNEUMONIAE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROIMMUNOFLUORESCENCE TEST; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEROPREVALENCE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; CHLAMYDOPHILA PNEUMONIAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN G; INFANT; RESPIRATORY TRACT INFECTIONS;

BACTERIA (MICROORGANISMS); CHLAMYDOPHILA; CHLAMYDOPHILA PNEUMONIAE; RICKETTSIALES;

EID: 2942566111     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.6.2476-2479.2004     Document Type: Article

References (38)

1. Aldous, M. B., J. T. Grayston, S. P. Wang, and H. M. Foy. 1992. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. J. Infect. Dis. 166:646-649.
2. Apfalter, P., F. Blasi, J. Boman, C. A. Gaydos, M. Kundi, M. Maass, A. Makristathis, A. Meijer, R. Nadrchal, K. Persson, M. L. Rotter, C. Y. Tong, G. Stanek, and A. M. Hirschl. 2001. Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J. Clin. Microbiol. 39:519-524.
3. Bennedsen, M., L. Berthelsen, and I. Lind. 2002. Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G, and A antibodies. Clin. Diagn. Lab. Immunol. 9:833-839.
4. Boman, J., and M. R. Hammerschlag. 2002. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin. Microbiol. Rev. 15:1-20.
5. Brade, L., H. Brunnemann, M. Ernst, Y. Fu, O. Holst, P. Kosma, H. Naher, K. Persson, and H. Brade. 1994. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. FEMS Immunol. Med. Microbiol. 8:27-41.
6. Byrne, G. I., S. P. Ouellette, Z. Wang, J. P. Rao, L. Lu, W. L. Beatty, and A. P. Hudson. 2001. Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect. Immun. 69:5423-5429.
7. Campbell, L. A., M. Perez Melgosa, D. J. Hamilton, C. C. Kuo, and J. T. Grayston. 1992. Detection of Chlamydia pneumoniae by polymerase chain reaction. J. Clin. Microbiol. 30:434-439.
8. Czerkinsky C., S. J. Prince, S. M. Michalek, S. Jackson, M. W. Russell, Z. Moldoveanu, J. R. McGhee, and J. Mestecky. 1987. IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc. Natl. Acad. Sci. USA 84:2449-2453.
9. Dowell, S. F., R. W. Peeling, J. Boman, G. M. Carlone, B. S. Fields, J. Guarner, M. R. Hammerschlag, L. A. Jackson, C. C. Kuo, M. Maass, T. O. Messmer, D. F. Talkington, M. L. Tondella, and S. R. Zaki. 2001. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin. Infect. Dis. 33:492-503.
10. Emre, U., P. M. Roblin, M. Gelling, W. Dumornay, M. Rao, M. R. Hammerschlag, and J. Schachter. 1994. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch. Pediatr. Adolesc. Med. 148:727-732.
11. Grayston, J. T., M. B. Aldous, A. Easton, S. P. Wang, C. C. Kuo, L. A. Campbell, and J. Altman. 1993. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J. Infect. Dis. 168:1231-1235.
12. Grayston, J. T., L. A. Campbell, C. C. Kuo, C. H. Mordhorst, P. Saikku, D. H. Thom, and S. P. Wang. 1990. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J. Infect. Dis. 161:618-625.
13. Groh, A., H. Holtz, M. Hartmann, and E. Straube. 2000. Comparison of the Chlamydia pneumoniae Western blot with serum from different patients which had a high IgG antibody titer in the microimmunofluorescence test, p. 137. In Pekka Saikku (ed.), Proceedings of the European Society for Chlamydia Research. Universitas Helsingiensis, Helsinki, Finland.
14. Hahn, D. L., A. A. Azenabor, W. L. Beatty, and G. I. Byrne. 2002. Chlamydia pneumoniae as a respiratory pathogen. Front. Biosci. 7:66-76.
15. Hammerschlag, M. R. 2000. Chlamydia pneumoniae and the lung. Eur. Respir. J. 16:1001-1007.
16. Hermann, C., K. Graf, A. Groh, E. Straube, and T. Hartung. 2002. Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals. J. Clin. Microbiol. 40:1603-1609.
17. Kalayoglu, M. V., P. Libby, and G. I. Byrne. 2002. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 288:2724-2731.
18. Kern, D. G., M. A. Neill, and J. Schachter. 1993. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest 104:208-213.
19. Kuo, C., and L. A. Campbell. 1998. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? Mol. Med. Today 4:426-430.
20. Kutlin, A., C. Flegg, D. Stenzel, T. Reznik, P. M. Roblin, S. Mathews, P. Timms, and M. R. Hammerschlag. 2001. Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model. J. Clin. Microbiol. 39:3721-3723.
21. Kutlin, A., P. M. Roblin, and M. R. Hammerschlag. 2002. Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model. J. Antimicrob. Chemother. 49:763-767.
22. Kutlin, A., P. M. Roblin, and M. R. Hammerschlag. 2002. Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection model. Antimicrob. Agents Chemother. 46:409-412.
23. Leinonen, M. 1993. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur. Heart J. 14(Suppl. K):57-61.
24. Materne, C., A. Oehme, G. Gaschler, and E. Straube. 2002. Chlamydia pneumoniae in the adenoid and tonsil of young children. Int. J. Med. Microbiol. 292:132-133.
25. Maurin, M., F. Eb, J. Etienne, and D. Raoult. 1997. Serological cross-reactions between Bartonella and Chiamydia species: implications for diagnosis. J. Clin. Microbiol. 35:2283-2287.
26. Mestecky, J., and J. R. McGhee. 1987. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:153-245.
27. Ngeh, J., V. Anand, and S. Gupta. 2002. Chlamydia pneumoniae and atherosclerosis-what we know and what we don't. Clin. Microbiol. Infect. 8:2-13.
28. Oehme, A., J. Berlau, A. Groh, M. Hartmann, and E. Straube. 1996. Comparison of two immunoassays for detection of Chlamydia trachomatis and evaluation of discrepant results by means of cell culture, PCR and serology. Clin. Lab. 42:843-846.
29. Oehme, A., and H. Freidank. 1999. Verfahren zum nachweis von antikörpern gegen Chlamydien. Hygiene Mikrobiol. 1:50-54.
30. Ozanne, G., and J. Lefebvre. 1992. Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections. Can. J. Microbiol. 38:1185-1189.
31. Peeling, R. W., S. P. Wang, J. T. Grayston, F. Blouse, J. Bemoan, A. Clad, H. Freidank, C. A. Gateways, J. Gnarpe, T. Hegira, R. B. Jones, J. Orfila, K. Persson, M. Puolakkainen, P. Saikku, and J. Schachter. 2000. Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J. Infect. Dis. 181:S426-S429.
32. Persson, K., and S. Haidi. 2000. Evaluation of a commercial test for antibodies to the chlamydial lipopolysaccharide (Medac) for serodiagnosis of acute infections by Chlamydia pneumoniae (TWAR) and Chlamydia psittaci. APMIS 108:131-138.
33. Saikku, P. 1992. The epidemiology and significance of Chlamydia pneumoniae. J. Infect. 25(Suppl. 1):27-34.
34. Smieja, M., J. Mahony, A. Petrich, J. Bemoan, and M. Chernesky. 2002. Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review. BMC Infect. Dis. 2:21.
35. Smieja, M., J. B. Mahony, C. H. Goldsmith, S. Chong, A. Petrich, and M. Chernesky. 2001. Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens. J. Clin. Microbiol. 39:1796-1801.
36. Verkooyen, R. P., D. Willemse, S. C. Hiep-van Casteren, S. A. Joulandan, R. J. Snijder, J. M. van den Bosch, H. P. van Helden, M. F. Peeters, and H. A. Verbrugh. 1998. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections. J. Clin. Microbiol. 36:2301-2307.
37. von Hertzen, L. 2002. Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae. Eur. Respir. J. 19:546-556.
38. Yucesan, C., and S. Sriram. 2001. Chlamydia pneumoniae infection of the central nervous system. Curr. Opin. Neurol. 14:355-359.